These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 35408980)
1. Exosomes in the Treatment of Pancreatic Cancer: A Moonshot to PDAC Treatment? Papadakos SP; Dedes N; Pergaris A; Gazouli M; Theocharis S Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408980 [TBL] [Abstract][Full Text] [Related]
2. Emerging Evidence for the Clinical Relevance of Pancreatic Cancer Exosomes. Massoumi RL; Hines OJ; Eibl G; King JC Pancreas; 2019 Jan; 48(1):1-8. PubMed ID: 30531240 [TBL] [Abstract][Full Text] [Related]
3. CKAP4, a DKK1 Receptor, Is a Biomarker in Exosomes Derived from Pancreatic Cancer and a Molecular Target for Therapy. Kimura H; Yamamoto H; Harada T; Fumoto K; Osugi Y; Sada R; Maehara N; Hikita H; Mori S; Eguchi H; Ikawa M; Takehara T; Kikuchi A Clin Cancer Res; 2019 Mar; 25(6):1936-1947. PubMed ID: 30610103 [TBL] [Abstract][Full Text] [Related]
4. Exosomes and the Future of Immunotherapy in Pancreatic Cancer. Batista IA; Melo SA Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30699928 [TBL] [Abstract][Full Text] [Related]
5. A Current Synopsis of the Emerging Role of Extracellular Vesicles and Micro-RNAs in Pancreatic Cancer: A Forward-Looking Plan for Diagnosis and Treatment. Trifylli EM; Kriebardis AG; Koustas E; Papadopoulos N; Fortis SP; Tzounakas VL; Anastasiadi AT; Sarantis P; Vasileiadi S; Tsagarakis A; Aloizos G; Manolakopoulos S; Deutsch M Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542378 [TBL] [Abstract][Full Text] [Related]
6. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients. Castillo J; Bernard V; San Lucas FA; Allenson K; Capello M; Kim DU; Gascoyne P; Mulu FC; Stephens BM; Huang J; Wang H; Momin AA; Jacamo RO; Katz M; Wolff R; Javle M; Varadhachary G; Wistuba II; Hanash S; Maitra A; Alvarez H Ann Oncol; 2018 Jan; 29(1):223-229. PubMed ID: 29045505 [TBL] [Abstract][Full Text] [Related]
7. Pancreatic Juice Exosomal MicroRNAs as Biomarkers for Detection of Pancreatic Ductal Adenocarcinoma. Nakamura S; Sadakari Y; Ohtsuka T; Okayama T; Nakashima Y; Gotoh Y; Saeki K; Mori Y; Nakata K; Miyasaka Y; Onishi H; Oda Y; Goggins M; Nakamura M Ann Surg Oncol; 2019 Jul; 26(7):2104-2111. PubMed ID: 30820789 [TBL] [Abstract][Full Text] [Related]
8. Exploring the potential of exosomes in diagnosis and drug delivery for pancreatic ductal adenocarcinoma. Xu B; Chen Y; Peng M; Zheng JH; Zuo C Int J Cancer; 2023 Jan; 152(2):110-122. PubMed ID: 35765844 [TBL] [Abstract][Full Text] [Related]
9. Tumor-released exosomal circular RNA PDE8A promotes invasive growth via the miR-338/MACC1/MET pathway in pancreatic cancer. Li Z; Yanfang W; Li J; Jiang P; Peng T; Chen K; Zhao X; Zhang Y; Zhen P; Zhu J; Li X Cancer Lett; 2018 Sep; 432():237-250. PubMed ID: 29709702 [TBL] [Abstract][Full Text] [Related]
10. Thinking small to win big? A critical review on the potential application of extracellular vesicles for biomarker discovery and new therapeutic approaches in pancreatic cancer. Vahabi M; Comandatore A; Centra C; Blandino G; Morelli L; Giovannetti E Semin Cancer Biol; 2023 Dec; 97():50-67. PubMed ID: 37956937 [TBL] [Abstract][Full Text] [Related]
11. Exosomes derived from human umbilical cord mesenchymal stromal cells deliver exogenous miR-145-5p to inhibit pancreatic ductal adenocarcinoma progression. Ding Y; Cao F; Sun H; Wang Y; Liu S; Wu Y; Cui Q; Mei W; Li F Cancer Lett; 2019 Feb; 442():351-361. PubMed ID: 30419348 [TBL] [Abstract][Full Text] [Related]
12. Can circulating tumor and exosomal nucleic acids act as biomarkers for pancreatic ductal adenocarcinoma? Liu DSK; Mato Prado M; Giovannetti E; Jiao LR; Krell J; Frampton AE Expert Rev Mol Diagn; 2019 Jul; 19(7):553-558. PubMed ID: 31159604 [No Abstract] [Full Text] [Related]
13. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway. Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515 [TBL] [Abstract][Full Text] [Related]
14. Exosomal integrins and their influence on pancreatic cancer progression and metastasis. Casari I; Howard JA; Robless EE; Falasca M Cancer Lett; 2021 Jun; 507():124-134. PubMed ID: 33741423 [TBL] [Abstract][Full Text] [Related]
16. Biomarker-Based Therapy in Pancreatic Ductal Adenocarcinoma: An Emerging Reality? Krantz BA; O'Reilly EM Clin Cancer Res; 2018 May; 24(10):2241-2250. PubMed ID: 29269376 [TBL] [Abstract][Full Text] [Related]
17. c-Met and PD-L1 on Circulating Exosomes as Diagnostic and Prognostic Markers for Pancreatic Cancer. Lux A; Kahlert C; Grützmann R; Pilarsky C Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284422 [TBL] [Abstract][Full Text] [Related]
18. Circular RNA IARS (circ-IARS) secreted by pancreatic cancer cells and located within exosomes regulates endothelial monolayer permeability to promote tumor metastasis. Li J; Li Z; Jiang P; Peng M; Zhang X; Chen K; Liu H; Bi H; Liu X; Li X J Exp Clin Cancer Res; 2018 Jul; 37(1):177. PubMed ID: 30064461 [TBL] [Abstract][Full Text] [Related]
19. The need for effective pancreatic cancer detection and management: a biomarker-based strategy. Crawley AS; O'Kennedy RJ Expert Rev Mol Diagn; 2015; 15(10):1339-53. PubMed ID: 26394703 [TBL] [Abstract][Full Text] [Related]
20. Cancer-derived small extracellular vesicles: emerging biomarkers and therapies for pancreatic ductal adenocarcinoma diagnosis/prognosis and treatment. Zhang W; Campbell DH; Walsh BJ; Packer NH; Liu D; Wang Y J Nanobiotechnology; 2022 Oct; 20(1):446. PubMed ID: 36242076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]